Latest Bioprocessing Podcast Episodes
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
Business Of Biotech - January 01, 2024 11:00 - 51 minutesWe love to hear from our listeners. Send us a message. A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On tod...
Biotech Down Under with BiomeBank's Dr. Sam Costello
Business Of Biotech - December 25, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, a former gastroenterologist-turned managing director and co-founder at Adelaide, Australia-b...
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
Business Of Biotech - December 18, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we welcome two extraordinary guests - Dr. Neela Patel, a molecular biologist-turned-Chief Business Officer, and Dr. John Mulligan, an academic-turned-founder of newly-formed Bonum Therapeu...
Public Sector Forged, Private Sector Tested with Renovaro BioSciences' Mark Dybul, M.D.
Business Of Biotech - December 11, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. During his leadership of the President's Emergency Plan for AIDS Relief during the George W. Bush administraion, Dr. Mark Dybul, M.D. shepherded programs credited with saving more than 25 million lives. For many years after that public se...
mRNA Vaccine Platforms with Combined Therapeutics' Dr. Romain Micol
Business Of Biotech - December 04, 2023 11:00 - 28 minutesWe love to hear from our listeners. Send us a message. Combined Therapeutics President & CEO Dr. Romain Micol is operating his company in a very noisy space, where hundreds of new biotechs have popped up on the coattails of a COVID-driven renewal of interest in mRNA vaccines. Micol recognizes ...
Biotech Dealmaking with Regeneron's Nouhad Husseini
Business Of Biotech - November 27, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. When it comes to landing and executing strategic partnerships, Regeneron puts on a clinic. Partnerships, acquisitions, licensing agreements, and other deals large and small with Intellia, Decibel Therapeutics, BARDA, Alnylam, and Sonoma Th...
Backpacks And Biotech with Luke Timmerman
Business Of Biotech - November 20, 2023 11:00 - 54 minutesWe love to hear from our listeners. Send us a message. From his vantage point as an independent biotech journalist, Luke Timmerman has been watching the expansions and retractions of the industry for a couple of decades now. His unique perspective is hard to equal, and that perspective is, des...
RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.
Business Of Biotech - November 13, 2023 11:00 - 54 minutesWe love to hear from our listeners. Send us a message. Earlier this year, Shawn Davis, Ph.D. left a pretty comfortable position at AstraZeneca (and Amgen before that, and Milliken, and others, before that) to lead Liberate Bio. He brought along another industry notable in Merck/Intellia alumnu...
The Legendary Steve Gorlin's Golden Rules
Business Of Biotech - November 06, 2023 11:00 - 57 minutesWe love to hear from our listeners. Send us a message. Shortly after Thalidomide became a household word—albeit a very, very bad one—a biotech investor bought it for a couple hundred grand. Who on earth would want a drug pulled from the market for causing birth defects? Steve Gorlin did. Tod...
UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono
Business Of Biotech - November 01, 2023 10:00 - 2 minutesWe love to hear from our listeners. Send us a message. Register for Business of Biotech Live! Legal & IP Protection For New Biotechs here. Get ready to unravel the legal enigmas of the biotech world with me and Keir LoIacono, Esq. The CEO of Blue Sphere Bio, Keir is no stranger to high-stakes ...
CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt
Business Of Biotech - October 30, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract develpment and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray ...
Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
Business Of Biotech - October 23, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. On a road trip to Boston, the Business of Biotech caught up with podcast alum Dan Passeri, J.D., CEO at Cue Biopharma, and enjoyed a two-for-one with CSO & President Anish Suri, Ph.D. at Cue's headquarters just feet below the Auerbach Cent...
Bio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.
Business Of Biotech - October 16, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Johanna Kaufmann, Ph.D.'s path to EVP, Oncology at Codagenix is part serendipity and part circumstance, but it's a much larger part hard work. On this week's episode of the Business of Biotech, Dr. Kaufmann gives us an intimate retrospecti...
Veteran Advice From The C-Suite with Citius' Leonard Mazur
Business Of Biotech - October 09, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, Leonard Mazur, co-founder, CEO, and chairman of Citius Pharmaceuticals, shares his rollercoaster ride to success in biotech, the founding story of Citius Pharmaceuticals, his engagement with the ...
Don't Be A D**k with Ochre Bio's Quin Wills, M.D., Ph.D.
Business Of Biotech - October 02, 2023 10:00 - 54 minutesWe love to hear from our listeners. Send us a message. Don't be offended by the title of today's Business of Biotech podcast. Dr. Quin Wills' application of what's become known as "Wheaton's Law" (look it up) is central to the ambitious goals his company, Ochre Bio, is pursuing: pioneering the...
Pragmatic Computational Biology with Andrew Satz
Business Of Biotech - September 25, 2023 10:00 - 59 minutesWe love to hear from our listeners. Send us a message. This week's guest on the Business of Biotech, EVQLV's Andrew Satz, says AI and ML in biopharma are like sex in high school. "Many of the people who say they're doing it really aren't, and the one who really are aren't talking about it," he...
Commercial Readiness with Orca Bio's Dan Kirby
Business Of Biotech - September 18, 2023 10:00 - 52 minutesWe love to hear from our listeners. Send us a message. Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played v...
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin
Business Of Biotech - September 11, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Core to the clinical-stage biopharma Life Bisociences belief set is that, "contrary to popular belief, aging is not caused by random wear and tear, but instead is caused by a discrete set of biological mechanisms that can be targeted thera...
Fiscal Turnarounds with Protalix's Eyal Rubin
Business Of Biotech - September 04, 2023 10:00 - 51 minutesWe love to hear from our listeners. Send us a message. Within about five minutes of conversation with Protalix CFO Eyal Rubin, I learned that he doesn’t bite his tongue about the rigors of biotech business and finance management, which is precisely why I’m eager to talk with him on today’s epi...
Building LEO Pharma's U.S. Presence with Brian Hilberdink
Business Of Biotech - August 28, 2023 10:00 - 52 minutesWe love to hear from our listeners. Send us a message. In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder; long-held cultural norms and management styles, region-specific market ...
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
Business Of Biotech - August 21, 2023 10:00 - 53 minutesWe love to hear from our listeners. Send us a message. Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both of small-but-mighty Rezolute Bio's candidates onto the next phases of their journey. This year, on the back of a $130 million investment, Rezolut...
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
Business Of Biotech - August 14, 2023 10:00 - 52 minutesWe love to hear from our listeners. Send us a message. The non-alcoholic steatohepatitis (NASH) therapeutics market has proven to be an 11/10 on the difficulty scale. Despite billions of big biopharma dollars invested in therapeutic development, and a few close calls, no therapeutics has yet r...
Biotech Cash Management with Allan Shaw
Business Of Biotech - August 07, 2023 10:00 - 47 minutesWe love to hear from our listeners. Send us a message. It’s been said that clinical trials are where emerging biotechs go to die. If the science doesn't kill quickly, poor cash management will slowly. And, even when good data opens the cash floodgates, post-round cash management savvy isn't ne...
Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
Business Of Biotech - July 31, 2023 10:00 - 47 minutesWe love to hear from our listeners. Send us a message. While Horizon Therapeutics has made plenty of waves in the biotech news cycle of late. While perhaps not as flashy as a perilous multibillion dollar acquisition deal or potential blockbuster readout, its formal establishment of a research ...
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Business Of Biotech - July 24, 2023 10:00 - 48 minutesWe love to hear from our listeners. Send us a message. The microbiome therapeutics market has been taking a beating, with several clinical-stage companies failing or flailing at the hands of tough financial markets and regulatory scrutiny. MaaT Pharma Founder & CEO Hervé Affagard knows these p...
COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
Business Of Biotech - July 17, 2023 10:00 - 46 minutesWe love to hear from our listeners. Send us a message. Chief Operating Officer is arguably the toughest job in the emerging biopharma C-suite. HR, CMC, regulatory affairs, legal, PR, you name it, the COO touches it, and practically everything rolls up to her. This week's episode of the Busines...
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
Business Of Biotech - July 10, 2023 10:00 - 46 minutesWe love to hear from our listeners. Send us a message. Will machine learning revolutionize biopharma drug discovery? Has it already? This week on the Business of Biotech, we explore the intersection of tech and bio with Dr. James Field, founder and CEO of LabGenius. We'll get an insider's look...
Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Business Of Biotech - July 03, 2023 10:00 - 47 minutesWe love to hear from our listeners. Send us a message. Ahmed Hamdy, MD didn’t ask to be the subject of Nathan Vardi's new book For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug. In fact, that particular chapter of Dr. Hamdy’s career is one he’d rather not relive...
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah
Business Of Biotech - June 26, 2023 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Last October, we dropped an episode dissecting the relationship between Ray Therapeutics and one of its lead funders, 4BIO, and it quickly rocketed to an all-time Business of Biotech fan favorite. This week, we’re doing it again with a can...
Population-Level Health Impact With Vaxxinity's John Krayacich
Business Of Biotech - June 19, 2023 10:00 - 48 minutesWe love to hear from our listeners. Send us a message. Vaxxinity’s John Krayacich likes taking big swings at big indications. He’s played key roles on the teams that launched Lipitor, Lyrica, and Neurontin, which have had measurable impacts on global populations of people suffering from cardio...
Related Bioprocessing Topics
- Biotech 2